13.66 USD
↗ 0.00 (0.00%)AT CLOSE (11:59 AM EDT)
Avalo Therapeutics, Inc. Common Stock
AVTXNASDAQ • USD
13.90
↗ 0.24 (1.72%)
POST MARKET (AS OF 06:32 PM EDT)
Post Market
AS OF 06:32 PM EDT
13.90
↗ 0.24 (1.72%)
Market: CLOSED
Open?$14.19
High?$14.28
Low?$13.25
Prev. Close?$13.66
Volume?726.1K
Avg. Volume?863.1K
VWAP?$13.63
Rel. Volume?0.84x
Bid / Ask
Bid?$13.65 × 100
Ask?$13.68 × 100
Spread?$0.03
Midpoint?$13.67
Valuation & Ratios
Market Cap?311.3M
Shares Out?22.8M
Float?14.5M
Float %?78.3%
P/E Ratio?N/A
P/B Ratio?3.40
EPS?-$4.38
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?14.27Strong
Quick Ratio?14.27Strong
Cash Ratio?3.38Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score58/100
P/E?N/A▾
P/B?3.40FAIR▾
P/S?1,621.30HIGH▾
P/FCF?N/A▾
EV/EBITDA?-4.3CHEAP▾
EV/Sales?1,480.87HIGH▾
Returns & Efficiency
ROE?-108.9%WEAK▾
ROA?-79.7%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$284.3M
Related Companies
Loading...
News
Profile
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
Employees
33
Market Cap
311.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2015-11-13
Address
1500 LIBERTY RIDGE DRIVE
WAYNE, PA 19087
Phone: 410-522-8707
WAYNE, PA 19087
Phone: 410-522-8707